The present disclosure describes novel heterocyclic mTOR inhibitors and methods for preparing them. The pharmaceutical compositions comprising such mTOR inhibitors and methods of using them for treating cancer, infectious diseases, and other mTOR associated disorders are also described.
本公开描述了新颖的杂环mTOR
抑制剂以及其制备方法。还描述了包含这些mTOR
抑制剂的药物组合物以及治疗癌症、传染病和其他mTOR相关疾病的使用方法。